Estimating risk factors for patients with potential drug-related problems using electronic pharmacy data

Annals of Pharmacotherapy

Volumn 33, Issue 4, 1999, Pages 406-412

  Isaksen, Sune Faurschou ^a,b   Jonassen, Jacob ^c   Malone, Daniel C ^a   Billups, Sarah J ^d   Carter, Barry L ^f   Sintek, Charles D ^e  

^a UNIVERSITY OF COLORADO   (United States)

^b Janssen Cilag   (Denmark)

^c NOVO NORDISK A S   (Denmark)

^d KAISER PERMANENTE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f Denver Vet Affairs Medical Center ^*

Author keywords

Computers; Drug related problems; Risk

Indexed keywords

AMIODARONE; CARBAMAZEPINE; CYCLOSPORIN; DIGOXIN; DRUG; ETHOSUXIMIDE; LITHIUM; METHOTREXATE; PHENOBARBITAL; PHENYTOIN; PROCAINAMIDE; QUINIDINE; THEOPHYLLINE; VALPROATE SEMISODIUM; VALPROIC ACID; WARFARIN;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CHRONIC DISEASE; CLINICAL PHARMACY; COMPUTER PROGRAM; DATA BASE; DOSE RESPONSE; DRUG INDUCED DISEASE; DRUG MONITORING; FEMALE; HIGH RISK PATIENT; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AMBULATORY CARE FACILITIES; AUTOMATIC DATA PROCESSING; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; PATIENT COMPLIANCE; PHARMACEUTICAL PREPARATIONS; PHARMACEUTICAL SERVICES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SOFTWARE;

EID: 0032914926     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.18268     Document Type: Article

References (28)

1. Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med 1995;155:1949-56.
2. Cunningham G, Dodd TR, Grant DJ, McMurdo ME, Richards RM. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing 1997; 26:375-82.
3. Manasse HR Jr. Medication use in an imperfect world: drug misadventuring as an issue of public policy, part 1. Am J Hosp Pharm 1989;46: 929-44.
4. Manasse HR Jr. Medication use in an imperfect world: drug misadventuring as an issue of public policy, part 2. Am J Hosp Pharm 1989;46: 1141-52.
5. Hepler CD, Strand LS. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
6. Lindley CM, Tully MP, Paramsothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992;21:294-300.
7. Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996;100:428-37.
8. Lobas NH, Lepinski PW, Abramowitz PW. Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory-care clinic. Am J Hosp Pharm 1992;49:1681-8.
9. Borgsdorf LR, Miano JS, Knapp KK. Pharmacist-managed medication review in a managed care system. Am J Hosp Pharm 1994;51:772-7.
10. Taylor KS. Pharmacists join the clinical team, enhancing outcomes, reducing costs. Hosp Health Netw 1994;68:69.
11. Bjornson DC, Hiner WO Jr, Potyk RP, Nelson BA, Lombardo FA, Morton TA, et al. Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm 1993;50:1875-84.
12. Bond CA, Monson R. Sustained improvement in drug documentation, compliance, and disease control. A four-year analysis of an ambulatory care model. Arch Intern Med 1984;144:1159-62.
13. Monson R, Bond CA, Schuna A. Role of the clinical pharmacists in improving drug therapy. Clinical pharmacists in outpatient therapy. Arch Intern Med 1981;141:1441-4.
14. Stanislav SW, Barker K, Crismon ML, Childs A. Effect of a clinical psychopharmacy consultation service on patient outcomes. Am J Hosp Pharm 1994;51:778-81.
15. Pitterle ME, Bond CA, Raehl CL, Franke T. Hospital and pharmacy characteristics associated with mortality rates in United States hospitals. Pharmacotherapy 1994;14:620-30.
16. Carter BL, Malone DC, Valuck RJ, Barnette DJ, Sintek CD, Billups SJ. The IMPROVE study: background and study design. Am J Health Syst Pharm 1998;55:62-7.
17. Koecheler JA, Abramowitz PW, Swim SE, Daniels CE. Indicators for the selection of ambulatory patients who warrant pharmacist monitoring. Am J Hosp Pharm 1989;46:729-32.
18. Malone DC, Billups SJ, Valuck RJ. Development of a chronic disease indicator score using a prescription database. J Clin Epidemiol (in press).
19. Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records. Med Care 1988;26: 814-23.
20. Altman DG. Practical statistics for medical research. New York: Chapman & Hall, 1991.
21. Jones B, Jarvis P, Lewis JA, Ebutt AF. Trials to assess equivalency: the importance of rigorous methods. BMJ 1996;313:36-9.
22. Young WW, Bell JE, Bouchard VE, Duffy MG. Clinical pharmacy services: prognostic criteria for selective patient monitoring, I. Am J Hosp Pharm 1974;31:562-8.
23. Young WW, Bell JE, Bouchard VE, Duffy MG. Clinical pharmacy services: prognostic criteria for selective patient monitoring, part II. Am J Hosp Pharm 1974;31:667-76.
24. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992;45:197-203.
25. Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992;45:1045-51.
26. Johnson RE, Hornbrook MC, Nichols GA. Replicating the chronic disease score (CDS) from automated pharmacy data. J Clin Epidemiol 1994;47:1191-9.
27. Clark DO, Von Korff M, Saunders K, Baluch WM, Simon GE. A chronic disease score with empirically derived weights. Med Care 1995;33: 783-95.
28. Kashner TM. Agreement between administrative files and written medical records: a case study of the Department of Veterans Affairs. Med Care 1998;36:1324-36.